comparemela.com

Page 9 - அந்தோணி அதல News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stem cell therapy shows potential to heal intestinal disease in premature infants

Stem cell therapy shows potential to heal intestinal disease in premature infants
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Study evaluates stem cells ability to prevent major cause of death in preterm infants

Study evaluates stem cells ability to prevent major cause of death in preterm infants A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at Samsung Medical Center, Sungkyunkwan University and Asan Medical Center Children s Hospital in Seoul, evaluates the effectiveness of treating these infants by transplanting umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) directly into their tracheas. Early results showed signs of improvement for the most immature infants included in the trial.

Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury

Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury Share Article A groundbreaking study from Neobiosis, a global expert in regenerative medicine, explains how a never-before-described process may open the door to regenerating damaged hearts. A peer-reviewed research paper from Dr. Ian White published in the journal Stem Cells and Regenerative Medicine explains how his studies of mouse hearts could be used to defeat a disease that kills 650,000 Americans each year. A revolutionary study may open the door to regenerating damaged hearts. We took a neonatal heart from a baby mouse and studied it in a petri dish. We studied it under a controlled environment and designed a method to keep the heart alive and keep the regenerative process active long enough to study the biology behind it.

Clinical trial assesses stem cells ability to prevent major cause of preemie deaths

Credit: AlphaMed Press Durham, NC - A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at Samsung Medical Center, Sungkyunkwan University and Asan Medical Center Children s Hospital in Seoul, evaluates the effectiveness of treating these infants by transplanting umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) directly into their tracheas. Early results showed signs of improvement for the most immature infants included in the trial. BPD is a serious breathing disorder in which the lungs do not develop normally. Most infants who develop BPD are born more than 10 weeks before their due date, weigh less than 2 pounds at birth, and have breathing problems. Infections that occur before or shortly after birth also can contribute to the disorder. Despite recent advances in neonatal m

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.